-
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-06-26
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for activating carboxyl groups in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It should be used exclusively in controlled in vitro laboratory settings, as there is currently no evidence to support its use in in vivo or clinical applications.
-
CDC42 Drives HBV Entry via NTCP Trafficking and Macropinocyt
2026-06-25
This study elucidates a dual mechanism by which the Rho GTPase CDC42 facilitates hepatitis B virus (HBV) entry into hepatocytes. By promoting NTCP translocation to the plasma membrane and enabling macropinocytosis, CDC42 emerges as a critical regulator of HBV infection, revealing new antiviral targets and expanding our understanding of host–virus interactions.
-
ATS-9R Enables Precision Gene Silencing for Adipose Inflamma
2026-06-25
Explore how ATS-9R (Adipocyte-targeting sequence-9-arginine) revolutionizes targeted gene delivery to adipose tissue, enabling advanced research on insulin resistance and metabolic inflammation. Uncover deeper mechanistic insights and translational considerations for obesity and GDM models.
-
Distinct Mechanisms of Chuanxiong Cortex and Pith in CHD The
2026-06-24
This study deciphers the spatial and chemical heterogeneity between the rhizome cortex and pith of Ligusticum chuanxiong in coronary heart disease (CHD) prevention. By integrating SPME-GC×GC-MS metabolomics with network pharmacology and molecular docking, it reveals tissue-specific bioactive compounds and mechanistic pathways, guiding precision use of herbal components in cardiovascular research.
-
Benzyl-activated Streptavidin Magnetic Beads: Applied Workfl
2026-06-23
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) from APExBIO deliver high-affinity, low-background capture of biotinylated molecules, optimizing workflows in protein and nucleic acid purification, immunoprecipitation, and advanced screening. This article dives into practical, data-backed protocols and troubleshooting strategies that set these beads apart in demanding molecular biology applications.
-
(-)-JQ1: Elevating Assay Rigor in Translational Epigenetics
2026-06-23
Explore how (-)-JQ1, the inactive JQ1 stereoisomer, is redefining assay rigor and mechanistic clarity in BET bromodomain research. This article bridges molecular specificity with translational strategy, drawing on pivotal cancer biology studies and the latest best practices. Discover actionable guidance for using (-)-JQ1 to advance epigenetics research and translational workflows, with contextual insights from APExBIO.
-
Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Oncol
2026-06-22
Carboplatin, a platinum-based DNA synthesis inhibitor, delivers robust, reproducible antiproliferative effects in both ovarian and lung cancer research models. This article guides scientists through advanced workflows, practical protocol enhancements, and troubleshooting strategies that maximize Carboplatin’s value in preclinical oncology. Learn how recent mechanistic insights and optimized assay design can elevate your experimental outcomes.
-
Neuromedin S (rat): Technical Guidance for GPCR Assays
2026-06-22
Neuromedin S (rat) provides a rigorously defined peptide agonist for activating neuromedin U receptor signaling in controlled rat GPCR/G protein research. It enables reproducible studies of energy homeostasis regulation and stress response, but is not suitable for diagnostic, therapeutic, or cross-species applications.
-
KU-55933: ATM Kinase Inhibitor for Precision Cancer Research
2026-06-21
KU-55933 empowers researchers to dissect DNA damage response pathways and induce cell cycle arrest with high selectivity and reproducibility. By leveraging APExBIO’s potent ATM kinase inhibitor, labs can implement robust experimental workflows, optimize cell-based assays, and troubleshoot solubility or signaling challenges commonly encountered in cancer research models.
-
Neuromedin S (rat): Technical Guidelines for GPCR Signaling
2026-06-20
Neuromedin S (rat) provides a chemically defined, endogenous neuromedin U receptor agonist for controlled rat GPCR/G protein signaling research. It enables standardized activation of neuromedin U receptor pathways critical for studies of energy homeostasis and stress response. Not suitable for diagnostic, therapeutic, or cross-species applications.
-
Screening BET/HDAC Inhibition Synergy in Pancreatic Cancer M
2026-06-19
This study establishes a rapid screening platform using Rgs16::GFP to identify promising chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). The work reveals that combined BET and HDAC inhibition, particularly with gemcitabine, produces synergistic anti-tumor effects, providing a translational framework for epigenetics-driven cancer therapy.
-
Reliable Cell Assays with Recombinant Human FGF-19 (E.coli,
2026-06-19
This article addresses real-world laboratory challenges in cell viability and metabolic regulation assays, providing scenario-driven guidance on the use of Recombinant Human FGF-19 (E.coli, Tag Free, Lyophilized) (SKU P1050). Drawing on validated performance data, it highlights how this reagent from APExBIO ensures reproducibility and sensitivity in FGF-19/FGFR4 pathway studies for biomedical researchers.
-
Budesonide in Precision Respiratory Research: Permeability,
2026-06-18
Explore Budesonide as a high-purity anti-inflammatory corticosteroid uniquely positioned for respiratory disease research. This article delivers a deep dive into advanced pulmonary permeability modeling and practical assay optimization, providing insights not found in existing content.
-
Strategic Poly(A) Tailing: Elevating mRNA for Translational
2026-06-18
This thought-leadership article examines the mechanistic, experimental, and translational implications of strategic RNA polyadenylation using the HyperScribe™ Poly (A) Tailing Kit from APExBIO. By integrating recent discoveries in cancer metastasis biology, it offers actionable guidance for researchers seeking to optimize mRNA stability and translation efficiency in advanced applications.
-
Baicalin Methyl Ester Restores Intestinal Barrier via P65 Pa
2026-06-17
This study demonstrates that baicalin methyl ester, an esterified derivative of baicalin, protects the intestinal barrier in LPS-challenged mice and MODE-K cells by modulating the P65/TNF-α/MLCK/ZO-1 signaling pathway. The findings clarify its mechanisms of action in reducing pro-inflammatory cytokines and restoring tight junction integrity, offering translational value for intestinal inflammation research.